These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38374618)

  • 21. To Study Adverse Effect following Immunization (AEFI) and COVID-19 Infection amongst COVID-19 Vaccine Benefeciaries.
    N PP; S CS; F JV; B AB; A KM; T DP; N GC; R IA
    J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States: a path to a more robust vaccine safety program.
    Salmon DA; Chen RT; Black S; Sharfstein J
    Expert Opin Drug Saf; 2024 Feb; 23(2):161-175. PubMed ID: 38343204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A global survey of adverse event following immunization surveillance systems for pregnant women and their infants.
    Cassidy C; MacDonald NE; Steenbeek A; Ortiz JR; Zuber PL; Top KA
    Hum Vaccin Immunother; 2016 Aug; 12(8):2010-2016. PubMed ID: 27159639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in Immunization Safety Monitoring - Worldwide, 2020-2022.
    Blau EF; Balakrishnan MR; Sköld H; Santhana Gopala Krishnan RS; Lundquist P; Pal S; Gidudu JF
    MMWR Morb Mortal Wkly Rep; 2023 Dec; 72(49):1321-1326. PubMed ID: 38060432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China.
    Hu Y; Li Q; Lin L; Chen E; Chen Y; Qi X
    Clin Vaccine Immunol; 2013 Feb; 20(2):211-7. PubMed ID: 23239804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine safety in Australia during the COVID-19 pandemic: Lessons learned on the frontline.
    Laemmle-Ruff I; Lewis G; Clothier HJ; Dimaguila GL; Wolthuizen M; Buttery J; Crawford NW
    Front Public Health; 2022; 10():1053637. PubMed ID: 36408022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 vaccine-related adverse events following immunization in the WHO Western Pacific Region, 2021-2022.
    Amarasinghe A; Cho H; Katalbas ER; Takashima Y
    Western Pac Surveill Response J; 2023; 14(2):1-11. PubMed ID: 37492235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
    Christou-Ergos M; Wiley KE; Leask J
    Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China.
    Lv H; Pan X; Wang Y; Liang H; Yu H
    Hum Vaccin Immunother; 2022 Nov; 18(5):2083865. PubMed ID: 35820038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.
    Alicino C; Merlano C; Zappettini S; Schiaffino S; Della Luna G; Accardo C; Gasparini R; Durando P; Icardi G
    Hum Vaccin Immunother; 2015; 11(1):91-4. PubMed ID: 25483520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. System and facility readiness assessment for conducting active surveillance of adverse events following immunization in Addis Ababa, Ethiopia.
    Zeleke ED; Yimer G; Lisanework L; Chen RT; Huang WT; Wang SH; Bennett SD; Makonnen E
    Int Health; 2023 Nov; 15(6):676-683. PubMed ID: 36622733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance of adverse events following immunisation in Australia annual report, 2021.
    Glover C; Deng L; Larter C; Brogan C; Richardson O; Huang YA; Kay E; Macartney K; Wood N
    Commun Dis Intell (2018); 2024 Jun; 48():. PubMed ID: 38926649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system.
    Pan X; Lv H; Chen F; Wang Y; Liang H; Shen L; Chen Y; Hu Y
    Hum Vaccin Immunother; 2021 Oct; 17(10):3823-3830. PubMed ID: 34170800
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India.
    Parida SP; Sahu DP; Singh AK; Alekhya G; Subba SH; Mishra A; Padhy BM; Patro BK
    J Med Virol; 2022 Jun; 94(6):2453-2459. PubMed ID: 35149993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
    Tran VN; Nguyen HA; Le TTA; Truong TT; Nguyen PT; Nguyen TTH
    Vaccine; 2021 Oct; 39(44):6485-6491. PubMed ID: 34607748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2018.
    Clothier HJ; Lawrie J; Lewis G; Russell M; Crawford NW; Buttery JP
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32536336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021.
    Gao D; Dong G; Zhu L; Jia N; Sun B
    Hum Vaccin Immunother; 2023 Aug; 19(2):2263225. PubMed ID: 37782096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imprecision in vaccine adverse event reporting and a methodological analysis of reporting systems to improve pharmacovigilance and public health.
    Inokuma Y; Kneller R
    Eur J Clin Pharmacol; 2023 Jul; 79(7):989-1002. PubMed ID: 37249640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
    Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
    Front Immunol; 2022; 13():956825. PubMed ID: 36177033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
    Glover C; Crawford N; Leeb A; Wood N; Macartney K
    Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.